Jianmin Pharmaceutical Group Co.,Ltd.

SHSE:600976 Stock Report

Market Cap: CN¥6.5b

Jianmin Pharmaceutical GroupLtd Balance Sheet Health

Financial Health criteria checks 5/6

Jianmin Pharmaceutical GroupLtd has a total shareholder equity of CN¥2.4B and total debt of CN¥150.9M, which brings its debt-to-equity ratio to 6.3%. Its total assets and total liabilities are CN¥4.2B and CN¥1.8B respectively. Jianmin Pharmaceutical GroupLtd's EBIT is CN¥164.3M making its interest coverage ratio -0.7. It has cash and short-term investments of CN¥1.1B.

Key information

6.3%

Debt to equity ratio

CN¥150.89m

Debt

Interest coverage ratio-0.7x
CashCN¥1.06b
EquityCN¥2.41b
Total liabilitiesCN¥1.80b
Total assetsCN¥4.21b

Recent financial health updates

Recent updates

Potential Upside For Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976) Not Without Risk

Nov 10
Potential Upside For Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976) Not Without Risk

If EPS Growth Is Important To You, Jianmin Pharmaceutical GroupLtd (SHSE:600976) Presents An Opportunity

Sep 25
If EPS Growth Is Important To You, Jianmin Pharmaceutical GroupLtd (SHSE:600976) Presents An Opportunity

Calculating The Fair Value Of Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976)

Aug 25
Calculating The Fair Value Of Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976)

The Market Doesn't Like What It Sees From Jianmin Pharmaceutical Group Co.,Ltd.'s (SHSE:600976) Earnings Yet As Shares Tumble 27%

Jul 12
The Market Doesn't Like What It Sees From Jianmin Pharmaceutical Group Co.,Ltd.'s (SHSE:600976) Earnings Yet As Shares Tumble 27%

We Think Jianmin Pharmaceutical GroupLtd (SHSE:600976) Can Stay On Top Of Its Debt

Jun 30
We Think Jianmin Pharmaceutical GroupLtd (SHSE:600976) Can Stay On Top Of Its Debt

We Ran A Stock Scan For Earnings Growth And Jianmin Pharmaceutical GroupLtd (SHSE:600976) Passed With Ease

May 21
We Ran A Stock Scan For Earnings Growth And Jianmin Pharmaceutical GroupLtd (SHSE:600976) Passed With Ease

We Think That There Are Issues Underlying Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Earnings

Apr 26
We Think That There Are Issues Underlying Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Earnings

Financial Position Analysis

Short Term Liabilities: 600976's short term assets (CN¥2.7B) exceed its short term liabilities (CN¥1.7B).

Long Term Liabilities: 600976's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥80.6M).


Debt to Equity History and Analysis

Debt Level: 600976 has more cash than its total debt.

Reducing Debt: 600976's debt to equity ratio has increased from 0% to 6.3% over the past 5 years.

Debt Coverage: 600976's debt is well covered by operating cash flow (136.7%).

Interest Coverage: 600976 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies